Tidmarsh is an executive-level physician/scientist and consultant. He is currently working with Citizen's Oncology Foundation and Solana Therapeutics among others. He has more than 20 years of experience and brings to Anavex a significant track record in clinical trials, FDA drug approvals and corporate growth.
"Dr. Tidmarsh has direct experience in successful early-stage trials, the ability to successfully expand emerging companies as well as expert pharmaceutical knowledge. We appreciate Dr. Tidmarsh's confidence in Anavex and believe his qualifications will help take the company to the next level,” said Harvey Lalach, president of Anavex.
